COMMUNIQUÉS West-GlobeNewswire

API and the University of Alberta Break Ground in Edmonton on Canada’s Largest Manufacturing Facility for Critical Medicines

20/06/2024 - 16:30

EDMONTON, Alberta, June 20, 2024 (GLOBE NEWSWIRE) -- Construction is set to begin on a crucial pharmaceutical manufacturing facility in the Edmonton Research Park that will provide Canadians with access to a stable [...]

Syntekabio Signs Memorandum of Understanding with bioSeedin/ACROBiosystems

20/06/2024 - 16:00

Companies to utilize bioSeedin global network to jointly promote synergistic products, technologies and services DAEJEON, South Korea, June 20, 2024 (GLOBE NEWSWIRE) -- Syntekabio (KOSDAQ: 226330), an artificial [...]

Wake Radiology’s Garner Office Honored as Outstanding CT Clinical Site for Spring 2024

20/06/2024 - 16:00

Raleigh, N.C., June 20, 2024 (GLOBE NEWSWIRE) -- Wake Radiology UNC REX Healthcare announced that Wake Technical Community College Computed Tomography (CT) students have awarded its Garner office as the Outstanding CT [...]

Lytus Technologies enters the audio entertainment sector with the launch of Radio Room, India's first regional Audio OTT platform

20/06/2024 - 15:48

Dubai, UAE, June 20, 2024 (GLOBE NEWSWIRE) -- Lytus Technologies Holdings PTV. Ltd. (the “Company”) (Nasdaq:LYT), a forward-thinking platform services entity with a strong track record of nurturing businesses at the [...]

NeuroOne® Granted Approval of ICD-10 Procedure Code for sEEG RF Ablation

20/06/2024 - 15:30

ICD-10-PCS code for first to market, FDA-cleared thin-film, sEEG-guided RF ablation system effective October 1, 2024 Specific procedure code positions OneRF ™ Ablation System for broader adoption and awareness [...]

Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives

20/06/2024 - 15:15

Financing led by existing and new investors DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced [...]

Centralis Health Expands and Enhances Connectivity Through Zen Healthcare IT

20/06/2024 - 15:13

Partnership with Zen Healthcare IT Ensures Centralis Health Participants Have Access to National Interoperability Networks TALLAHASSEE, Fla., June 20, 2024 (GLOBE NEWSWIRE) -- Centralis Health, a regional health [...]

Brain Canada Launches $26 Million Platform Support Grants (PSG) Program to Accelerate Neuroscience and Mental Health Research

20/06/2024 - 15:02

MONTREAL, June 20, 2024 (GLOBE NEWSWIRE) -- Brain Canada is thrilled to announce the launch of the 2024 Platform Support Grants (PSG) program, a groundbreaking initiative designed to bridge a critical gap in the [...]

La Fondation Brain Canada alloue 26 M$ pour lancer le programme Subventions de soutien aux plateformes (SSP) afin d’accélérer la recherche en neurosciences et en santé mentale

20/06/2024 - 15:02

MONTRÉAL, 20 juin 2024 (GLOBE NEWSWIRE) -- La Fondation Brain Canada est fière d’annoncer le lancement du programme Subventions de soutien aux plateformes 2024, une initiative novatrice conçue pour remédier au manque de [...]

Altamira Therapeutics Highlights Newly Published Review Article Supporting Use of Betahistine in Vertigo Management

20/06/2024 - 15:01

Hamilton, Bermuda, June 20, 2024 (GLOBE NEWSWIRE) -- Independent review discusses evidence supporting the use of betahistine to alleviate residual dizziness following physical repositioning procedures in benign [...]

Shineco Enters into a Letter of Intent with Meitong Technology to Address China’s Aging Population

20/06/2024 - 15:00

BEIJING, June 20, 2024 (GLOBE NEWSWIRE) -- Shineco Inc. (“Shineco” or the “Company”; NASDA: SISI), a producer of innovative diagnostic medical products and related medical devices announced today that on June 18, 2024, [...]

Scilex Holding Company Partners with New National Distributor, Endeavor Distribution LLC.

20/06/2024 - 15:00

PALO ALTO, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or the “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non- [...]

Firefly Neuroscience, an AI-Driven Brain Health Company, Appoints Samer Kaba, MD as Chief Medical Officer

20/06/2024 - 15:00

Firefly expands its leadership team as it nears the closing of its merger with WaveDancer FAIRFAX, Va. and TORONTO, June 20, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. (“Firefly” or the “Company”), a pioneering [...]

New Survey from Progyny Shows Strong LGBTQ+ Demand for Inclusive Family Building Benefits

20/06/2024 - 14:59

NEW YORK, June 20, 2024 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a transformative fertility, family building, and women’s health benefits solution, today released findings from its 2024 LGBTQ+ family building [...]

ClearPoint Neuro Congratulates Partner Aspen Neuroscience on Use of the ClearPoint® Navigation System for All Enrolled Patients in ASPIRO Clinical Trial

20/06/2024 - 14:45

Parkinson’s Disease Clinical Trial Uses Intraoperative MRI to Guide Precision Implantation of Patients’ Own Autologous Replacement Neurons SOLANA BEACH, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. ( [...]

Avenue Therapeutics to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference

20/06/2024 - 14:30

MIAMI, June 20, 2024 (GLOBE NEWSWIRE) -- Avenue Therapeutics, Inc. (Nasdaq: ATXI) (“Avenue” or the “Company”), a specialty pharmaceutical company focused on the development and commercialization of therapies for the [...]

Adial Pharmaceuticals Announces Publication in Leading Peer-Reviewed Journal Supporting the Potential Efficacy of AD04 as a Precision Medicine for the Treatment of Alcohol Use Disorder

20/06/2024 - 14:30

AD04 reduced heavy drinking days among heavy drinking individuals with alcohol use disorder and a specific genetic profile, as identified by a companion diagnostic test (CDx) GLEN ALLEN, Va., June 20, 2024 (GLOBE [...]

Nexalin Technology Awarded Key Patent Related to its Non-Invasive, Frequency-Based Deep-Brain Stimulation Device for the Treatment of Alzheimer’s and Dementia

20/06/2024 - 14:30

HOUSTON, TEXAS, June 20, 2024 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) today announced that the United States Patent and Trademark Office (USPTO) has awarded U.S. [...]

Aphaia Pharma Announces Positive Results from Phase 2 Trial Evaluating its Lead Drug Formulation for Prediabetes Treatment

20/06/2024 - 14:30

Primary endpoint met, showing that APHD-012 improves glucose tolerance in individuals with a pathological oral glucose tolerance test (OGTT) after 6 weeks of administration The results provide proof-of-concept for [...]